Indutrade Agrees to Acquire Polish Life Science Firm Sinmed
Indutrade agreed to acquire all shares of Poland-based Sinmed, which has approximately PLN 50 million (SEK 130 million) in annual sales. Closing is subject to Polish competition authority approval and is expected in Q4 2026; the deal is seen as marginally EPS-positive.